These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11792005)

  • 41. Unpredictable checks of yellow fever vaccination certificates upon arrival in Tanzania.
    Schönenberger S; Hatz C; Bühler S
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27296582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of yellow fever vaccination practice in England.
    Bryant N; Tucker R; Simons H; Bailey S; Mathewson J; Lea G; Hill DR
    J Travel Med; 2008; 15(5):287-93. PubMed ID: 19006500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Yellow fever.
    Monath TP; Vasconcelos PF
    J Clin Virol; 2015 Mar; 64():160-73. PubMed ID: 25453327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pandemic yellow fever: a potential threat to global health via travelers.
    Gubler DJ
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30299494
    [No Abstract]   [Full Text] [Related]  

  • 45. Yellow fever vaccination.
    Middleton D
    Lancet; 1999 Jan; 353(9147):154. PubMed ID: 10023934
    [No Abstract]   [Full Text] [Related]  

  • 46. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yellow fever as an endemic/epidemic disease and priorities for vaccination.
    Monath TP
    Bull Soc Pathol Exot; 2006 Dec; 99(5):341-7. PubMed ID: 17253051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yellow fever outbreaks, vaccine shortages and the Hajj and Olympics: call for global vigilance.
    Elachola H; Ditekemena J; Zhuo J; Gozzer E; Marchesini P; Rahman M; Sow S; Kattan RF; Memish ZA
    Lancet; 2016 Sep; 388(10050):1155. PubMed ID: 27609407
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunization for overseas travel.
    Cannon DA
    Trans R Soc Trop Med Hyg; 1969; 63(6):867-80. PubMed ID: 5392262
    [No Abstract]   [Full Text] [Related]  

  • 51. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of two yellow fever vaccines for routine immunization programs in Argentina.
    Ripoll C; Ponce A; Wilson MM; Sharif N; Vides JB; Armoni J; Teuwen DE
    Hum Vaccin; 2008; 4(2):121-6. PubMed ID: 18382132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health challenges of young travelers visiting friends and relatives compared with those traveling for other purposes.
    Han P; Yanni E; Jentes ES; Hamer DH; Chen LH; Wilson ME; Macleod WB; Ooi WW; Kogelman L; Karchmer AW; Barnett ED
    Pediatr Infect Dis J; 2012 Sep; 31(9):915-9. PubMed ID: 22895214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
    Cetron MS; Marfin AA; Julian KG; Gubler DJ; Sharp DJ; Barwick RS; Weld LH; Chen R; Clover RD; Deseda-Tous J; Marchessault V; Offit PA; Monath TP
    MMWR Recomm Rep; 2002 Nov; 51(RR-17):1-11; quiz CE1-4. PubMed ID: 12437192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Yellow fever vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP).
    MMWR Recomm Rep; 1990 May; 39(RR-6):1-6. PubMed ID: 2159593
    [No Abstract]   [Full Text] [Related]  

  • 59. First case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong Kong.
    Leung WS; Chan MC; Chik SH; Tsang TY
    J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27087559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Yellow fever, 1996-1997. Part II.
    Wkly Epidemiol Rec; 1998 Nov; 73(47):370-2. PubMed ID: 9844551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.